Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BL-M05D1 |
| Trade Name | |
| Synonyms | BLM05D1|BL M05D1 |
| Drug Descriptions |
BL-M05D1 is an antibody-drug conjugate (ADC) comprising a monoclonal antibody targeting CLDN18.2 linked to the topoisomerase I inhibitor Ed-04, which potentially inhibits growth of tumors expressing CLDN18.2 (Cancer Res (2024) 84 (6_Supplement): 3140). |
| DrugClasses | CLDN18.2 Antibody 23 |
| CAS Registry Number | NA |
| NCIT ID | C215079 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BL-M05D1 | BL-M05D1 | 0 | 1 |